Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
不依赖冷链、无针粘膜病毒体疫苗,可预防粘膜水平的 HIV-1 感染
基本信息
- 批准号:10072724
- 负责人:
- 金额:$ 72.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY – OVERALL
This multi-PI application is a collaboration between Mymetics and the Texas Biomedical Research Institute
(TxBiomed), with Drs. Sylvain Fleury (Project 1 Lead; Mymetics) and Ruth Ruprecht (Project 2 Lead; TxBiomed)
serving as PIs. We seek to bring a promising HIV/AIDS vaccine approach to the clinic. The vaccine is based
upon influenza virosomes, enveloped virus-like particles that display on their surface elongated HIV gp41
peptides (virosome-P1) or recombinant truncated HIV gp41 (virosome-rgp41). Mymetics' Phase I clinical trial
with virosome-P1 in healthy women showed safety and immunogenicity. Two independent nonhuman primate
(NHP) studies demonstrated the safety and high efficacy of the combination of virosome-P1 + virosome rgp41
against repeated low-dose intravaginal challenges with a tier 2 R5 SHIV in Chinese and Indian-origin rhesus
macaques (RMs). In the latter, 78-87% efficacy was noted when the SHIV challenge dose was ~7x104 times the
median HIV inoculum in male-to-female HIV transmission. However, when this HIV inoculum was exceeded 105-
fold by an even higher SHIV inoculum, protection in Indian RMs was lost, implying a threshold effect whereby
vaccine-induced mucosal antibodies were unable to ward off the higher number of invading SHIV particles. The
soluble vaccine used in both NHP studies was unadjuvanted. To improve immunogenicity, Mymetics has
embedded the toll-like receptor (TLR)7/8 adjuvant 3M-052 into virosomal envelopes. Moreover, Mymetics has
developed a powdered form of virosomes that is no longer cold-chain dependent and can be administered as
intranasal (IN) spray, sublingual (SL) tablets, or packaged into oral capsules. We hypothesize that these novel
solid virosome formulations are significantly more immunogenic, particularly when administered via mucosal
routes, than the unadjuvanted liquid form used earlier in NHPs. The Specific Aims of this IPCAVD project are to:
1. Assess the immunogenicity of the new vaccine candidates, the newly 3M-052-adjuvanted HIV virosome-P1
and virosome-rgp41, under solid dosage forms delivered IN, SL, or orally to Indian RMs in order to select the
two most immunogenic formulations for subsequent mucosal prime/mucosal boost immunization.
2. Assess the efficacy of the cold-chain independent virosomal vaccine delivered by combined mucosal
immunization routes against repeated intrarectal challenges with the heterologous R5 clade B SHIVSF162P3.
Protected RMs will be rechallenged with an R5 tier 2 clade C SHIV.
3. Optimize the GMP manufacturing process for the selected virosomal formulations for mucosal delivery, and
4. Perform toxicology studies to show good safety profiles of the adjuvanted, solid-form vaccines given by
selected mucosal routes – and generate GMP vaccine for a Phase I trial to be conducted with the HVTN.
Our vaccine development plans represent major advances, as the novel needle-free, solid vaccine dosage forms
are cold-chain independent and will be mucosally delivered – unique aspects that make the novel virosomal
vaccines especially attractive for the developing world, where the AIDS epidemic remains a serious problem.
项目总结-整体
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sylvain FLEURY其他文献
Sylvain FLEURY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sylvain FLEURY', 18)}}的其他基金
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
不依赖冷链、无针粘膜病毒体疫苗,可预防粘膜水平的 HIV-1 感染
- 批准号:
10401878 - 财政年份:2019
- 资助金额:
$ 72.72万 - 项目类别:
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
不依赖冷链、无针粘膜病毒体疫苗,可预防粘膜水平的 HIV-1 感染
- 批准号:
10624796 - 财政年份:2019
- 资助金额:
$ 72.72万 - 项目类别:
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
不依赖冷链、无针粘膜病毒体疫苗,可预防粘膜水平的 HIV-1 感染
- 批准号:
10158409 - 财政年份:2019
- 资助金额:
$ 72.72万 - 项目类别:
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
不依赖冷链、无针粘膜病毒体疫苗,可预防粘膜水平的 HIV-1 感染
- 批准号:
9919543 - 财政年份:2019
- 资助金额:
$ 72.72万 - 项目类别:
相似国自然基金
Supply Chain Collaboration in addressing Grand Challenges: Socio-Technical Perspective
- 批准号:
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国青年学者研究基金项目
在大数据和复杂模型背景下探究更有效的Markov chain Monte Carlo算法
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
构建互穿网络结构中系带分子(tie chain)和缠结网络协同提升全聚合物太阳能电池力学与光伏性能
- 批准号:52003269
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于Service Chain的数据中心网络资源调度问题研究
- 批准号:61772235
- 批准年份:2017
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
EAGER: Search-Accelerated Markov Chain Monte Carlo Algorithms for Bayesian Neural Networks and Trillion-Dimensional Problems
EAGER:贝叶斯神经网络和万亿维问题的搜索加速马尔可夫链蒙特卡罗算法
- 批准号:
2404989 - 财政年份:2024
- 资助金额:
$ 72.72万 - 项目类别:
Standard Grant
Collaborative Research: Chain Transform Fault: Understanding the dynamic behavior of a slow-slipping oceanic transform system
合作研究:链变换断层:了解慢滑海洋变换系统的动态行为
- 批准号:
2318855 - 财政年份:2024
- 资助金额:
$ 72.72万 - 项目类别:
Continuing Grant
言語の壁を超える低資源多言語Machine Speech Chain技術の構築
构建克服语言障碍的低资源多语言机器语音链技术
- 批准号:
23K21681 - 财政年份:2024
- 资助金额:
$ 72.72万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
EcoTraceAI: A Novel AI-based Platform for data collection and validation for measuring the environmental impacts of the supply chain in the fashion industry.
EcoTraceAI:一个基于人工智能的新型平台,用于数据收集和验证,用于衡量时尚行业供应链的环境影响。
- 批准号:
10114149 - 财政年份:2024
- 资助金额:
$ 72.72万 - 项目类别:
SME Support
SUstainable EuroPean Rare Earth Elements production value chain from priMary Ores
来自原矿的可持续欧洲稀土元素生产价值链
- 批准号:
10091569 - 财政年份:2024
- 资助金额:
$ 72.72万 - 项目类别:
EU-Funded
An Integrated Value Chain for the Coffee Industry
咖啡行业的综合价值链
- 批准号:
10078431 - 财政年份:2024
- 资助金额:
$ 72.72万 - 项目类别:
Collaborative R&D
A Data-Centric Mobile Edge Platform for Resilient Logistics & Supply Chain
以数据为中心的移动边缘平台,实现弹性物流
- 批准号:
LP220200893 - 财政年份:2024
- 资助金额:
$ 72.72万 - 项目类别:
Linkage Projects
An explainability oriented approach to manage dependent supply chain risks
一种以可解释性为导向的方法来管理相关供应链风险
- 批准号:
LP230100379 - 财政年份:2024
- 资助金额:
$ 72.72万 - 项目类别:
Linkage Projects
Revolutionising the Defence Supply Chain through Space-enabled Materials & Manufacturing Processes (M&MP)
通过太空材料彻底改变国防供应链
- 批准号:
10087518 - 财政年份:2024
- 资助金额:
$ 72.72万 - 项目类别:
Collaborative R&D
CAREER: Elucidating the Impact of Side-Chain Topology on the Structure-Property Relationship in Bottlebrush Polymers
职业:阐明侧链拓扑对洗瓶刷聚合物结构-性能关系的影响
- 批准号:
2340664 - 财政年份:2024
- 资助金额:
$ 72.72万 - 项目类别:
Continuing Grant